特比萘芬所致肝损伤：一例报告
Terbinafine induced liver injury: a case report.
作者信息
Choudhary Narendra S, Kotecha Hardik, Saraf Neeraj, Gautam Dheeraj, Saigal Sanjiv
机构信息
Institute of Liver Transplantation and Regenerative Medicine, Medanta, The Medicity, Sector 38, Gurgaon, Haryana, India.
Institute of Digestive and Hepatobiliary Sciences, Medanta, The Medicity, Sector 38, Gurgaon, Haryana, India.
出版信息
J Clin Exp Hepatol. 2014 Sep;4(3):264-5. doi: 10.1016/j.jceh.2014.03.040. Epub 2014 Apr 3.
Abstract
Drug induced liver injury (DILI) is a cause of significant morbidity; timely diagnosis is important and requires a high index of suspicion. Terbinafine induced liver injury is rare. We report a case of Terbinafine induced hepatitis-cholestatic injury. The patient had a prolonged recovery phase lasting 3 months after discontinuation of drug.
摘要
药物性肝损伤（DILI）是导致严重发病的一个原因；及时诊断很重要，且需要高度的怀疑指数。特比萘芬所致肝损伤较为罕见。我们报告一例特比萘芬所致的肝炎-胆汁淤积性损伤病例。该患者在停药后有一个持续3个月的漫长恢复期。
相似文献
1
Terbinafine induced liver injury: a case report.特比萘芬所致肝损伤：一例报告
J Clin Exp Hepatol. 2014 Sep;4(3):264-5. doi: 10.1016/j.jceh.2014.03.040. Epub 2014 Apr 3.
2
Drug-induced liver injury.药物性肝损伤。
Mayo Clin Proc. 2014 Jan;89(1):95-106. doi: 10.1016/j.mayocp.2013.09.016.
3
Terbinafine-Induced Liver Injury: A Case Report.特比萘芬所致肝损伤：一例报告
Cureus. 2023 Dec 18;15(12):e50749. doi: 10.7759/cureus.50749. eCollection 2023 Dec.
4
The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine.HLA-A*33:01 与特比萘芬相关性胆汁淤积性肝炎患者的关系。
J Hepatol. 2018 Dec;69(6):1317-1325. doi: 10.1016/j.jhep.2018.08.004. Epub 2018 Aug 21.
5
Drug-Induced Liver Injury Secondary to Terbinafine Use.特比萘芬使用继发的药物性肝损伤
Cureus. 2024 Feb 19;16(2):e54453. doi: 10.7759/cureus.54453. eCollection 2024 Feb.
6
Idiosyncratic drug-induced liver injury: an overview.特异质性药物性肝损伤：概述
Expert Opin Drug Saf. 2007 Nov;6(6):673-84. doi: 10.1517/14740338.6.6.673.
7
Terbinafine-induced cholestatic liver disease.特比萘芬诱发的胆汁淤积性肝病。
J Hepatol. 1996 Jun;24(6):753-6. doi: 10.1016/s0168-8278(96)80273-x.
8
Norethisterone Related Drug Induced Liver Injury: A Series of 3 Cases.炔诺酮相关药物性肝损伤：3例系列报道
J Clin Exp Hepatol. 2017 Sep;7(3):266-268. doi: 10.1016/j.jceh.2017.01.001. Epub 2017 Apr 21.
9
Clinical presentation of terbinafine-induced severe liver injury and the value of laboratory monitoring: a Critically Appraised Topic.特比萘芬致严重肝损伤的临床表现及实验室监测的价值：一项批判性评价课题。
Br J Dermatol. 2017 Nov;177(5):1279-1284. doi: 10.1111/bjd.15854. Epub 2017 Oct 11.
10
Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts.特比萘芬引起的伴有小叶间胆管减少的长期胆汁淤积。
Dig Dis Sci. 1997 Jul;42(7):1486-8. doi: 10.1023/a:1018870828038.
引用本文的文献
1
Terbinafine-Induced Liver Injury: A Case Report.特比萘芬所致肝损伤：一例报告
Cureus. 2023 Dec 18;15(12):e50749. doi: 10.7759/cureus.50749. eCollection 2023 Dec.
2
Concurrent terbinafine-induced acute generalised exanthematous pustulosis and hepatitis.同时发生的特比萘芬诱导的急性泛发性发疹性脓疱病和肝炎。
BMJ Case Rep. 2021 Jan 18;14(1):e238930. doi: 10.1136/bcr-2020-238930.
3
Quinolines derivatives as promising new antifungal candidates for the treatment of candidiasis and dermatophytosis.喹啉衍生物作为治疗念珠菌病和皮肤癣菌病的有前景的新型抗真菌候选药物。
Braz J Microbiol. 2020 Dec;51(4):1691-1701. doi: 10.1007/s42770-020-00348-4. Epub 2020 Jul 31.
4
Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation.综合动力学和建模分析表明，CYP2C9 和 3A4 决定了特比萘芬的代谢清除率和生物活化。
Biochem Pharmacol. 2019 Dec;170:113661. doi: 10.1016/j.bcp.2019.113661. Epub 2019 Oct 9.
5
Analysis of Time-Series Gene Expression Data to Explore Mechanisms of Chemical-Induced Hepatic Steatosis Toxicity.分析时间序列基因表达数据以探索化学诱导的肝脂肪变性毒性机制。
Front Genet. 2018 Sep 18;9:396. doi: 10.3389/fgene.2018.00396. eCollection 2018.
6
In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species.体外抗真菌药物三联疗法治疗临床帚霉属和皮壳霉属物种。
Antimicrob Agents Chemother. 2015 Aug;59(8):5040-3. doi: 10.1128/AAC.00145-15. Epub 2015 May 26.
本文引用的文献
1
Case definition and phenotype standardization in drug-induced liver injury.药物性肝损伤的病例定义和表型标准化。
Clin Pharmacol Ther. 2011 Jun;89(6):806-15. doi: 10.1038/clpt.2011.58. Epub 2011 May 4.
2
Practical guidelines for diagnosis and early management of drug-induced liver injury.药物性肝损伤诊断与早期管理实用指南
World J Gastroenterol. 2008 Nov 28;14(44):6774-85. doi: 10.3748/wjg.14.6774.
3
Causality assessment of drug-induced hepatotoxicity: promises and pitfalls.药物性肝毒性的因果关系评估：前景与陷阱
Clin Liver Dis. 2007 Aug;11(3):477-505, v. doi: 10.1016/j.cld.2007.06.003.
4
Terbinafine-induced hepatic failure requiring liver transplantation.特比萘芬所致肝衰竭需进行肝移植。
Liver Transpl. 2007 Jan;13(1):162-4. doi: 10.1002/lt.21034.
5
Terbinafine induced prolonged cholestasis: case report and review of the literature.特比萘芬诱发的长期胆汁淤积：病例报告及文献综述
Turk J Gastroenterol. 2002 Sep;13(3):180-2.
6
Ursodeoxycholic acid for terbinafine-induced toxic hepatitis.熊去氧胆酸治疗特比萘芬所致中毒性肝炎。
Ann Pharmacother. 2004 Jun;38(6):1088-9. doi: 10.1345/aph.1D420. Epub 2004 Apr 30.
7
Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis.特比萘芬肝毒性导致慢性胆管减少和门脉纤维化。
Am J Med. 2002 Jun 15;112(9):741-2. doi: 10.1016/s0002-9343(02)01109-9.
8
Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity.特比萘芬反应性代谢产物的鉴定：对特比萘芬所致肝毒性的见解。
Chem Res Toxicol. 2001 Feb;14(2):175-81. doi: 10.1021/tx0002029.
9
Hepatitis associated with terbinafine therapy: three case reports and a review of the literature.特比萘芬治疗相关的肝炎：三例病例报告及文献综述
Clin Exp Dermatol. 1998 Mar;23(2):64-7. doi: 10.1046/j.1365-2230.1998.00321.x.
Zotero 插件